According to The Block, VitaDAO, a decentralized autonomous organization aimed at funding longevity research projects, has completed $4.1 million in financing. Investors include Pfizer Ventures Pfizer Ventures, Shine Capital, L1 Digital, and Balaji Srinivasan. The project aims to use the funds to further fund longevity research projects and biotech startups that will be spun out of the DAO next year. In September 2022, Pfizer invested $500,000 in VitaDAO to accelerate longevity research and development. DeSci aims to replace the current scientific ecosystem that relies on centralized research and funding agencies. It aims to raise funds for research through crowdfunding and decentralized ownership. VitaDAO-funded projects focus on longevity and aging.